
Visentin succeeds Dr. Benjamin Reinmann, effective March 1, 2025. He brings more than 20 years of healthcare experience to Enovis, a Wilmington, Delaware-based orthopedic company.
Most recently, Visentin served as VP and GM of the Integrated Diagnostic Solutions business unit at BD. There, he managed more than 700 employees across 50 countries. Before BD, he served as VP and GM of Europe for Stryker’s Joint Replacement and Robotic Division. He also spent time as VP, EMEA, for Johnson & Johnson’s DePuy Synthes orthopedics business.
Louie Vogt, group president of the Enovis Reconstructive unit, said Reinmann’s leadership helped create a world-class International Surgical business.”
“We sincerely thank Benjamin for his numerous contributions to the growth and success of both Enovis and Mathys, and especially throughout the critical integration of legacy companies Mathys and LimaCorporate,” said Vogt.
Vogt went on to call Visentin a “dynamic leader” with a strong track record in growing businesses along with a passion for orthopedics. He said Visentin has “the experience and playbook to take our business to the next level.”
“We continue to make great progress with building and growing our International Surgical Business into a global orthopedics leader that is thriving because of our team’s commitment to excellence and to going above and beyond every day to create better together,” said Vogt. “The momentum we created in 2024 puts us in a strong position to advance our strategic goals, continue gaining market share and drive growth through innovation, all with the ultimate goal of improving patient outcomes.”